生物医药公司亚盛医药-B(06855)今日盘中出现大幅波动，股价一度下跌超过5%，引发市场的广泛关注。不过，分析师对此并不过于担心。
事实上，亚盛医药-B刚刚在1月24日完成赴美上市,登录纳斯达克市场,并成功募集1.26亿美元。方正证券分析师认为,这一举措将有助于公司进一步拓宽融资渠道,增强资金实力,为公司未来研发、商业化运作提供更多支持,加速其核心产品耐立克等的全球推广。
基于上述利好因素,方正证券分析师维持亚盛医药-B股票"强烈推荐"的评级,看好公司未来的业绩表现。因此,亚盛医药-B今日的股价下跌或许只是市场的短期过度反应,长远来看仍存在投资机会。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.